0001999371-24-002950.txt : 20240229
0001999371-24-002950.hdr.sgml : 20240229
20240229170623
ACCESSION NUMBER: 0001999371-24-002950
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240227
FILED AS OF DATE: 20240229
DATE AS OF CHANGE: 20240229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRIS JESSICA EDGAR
CENTRAL INDEX KEY: 0001656531
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 24704945
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
BUSINESS PHONE: 212-980-9155
MAIL ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
ownership.xml
CHANGES OF BENEFICIAL OWNERSHIP
X0508
4
2024-02-27
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001656531
MORRIS JESSICA EDGAR
C/O TONIX PHARMACEUTICALS HOLDING CORP.
26 MAIN ST., SUITE 101
CHATHAM
NJ
07928
0
1
0
0
Chief Operating Officer
0
Stock Option
0.368
2024-02-27
4
A
0
317000
0.00
A
2025-02-27
2034-02-27
Common Stock
317000
317000
D
Stock Option
0.46
2024-02-27
4
A
0
317000
0.00
A
2025-02-27
2034-02-27
Common Stock
317000
317000
D
One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
/s/ Jessica Morris
2024-02-29